VMP 36049511000001109

Search dm+d | This VMP cannot be matched against our prescribing data.

Name Irinotecan 100mg/5ml solution for infusion vials
BNF code 0801050Q0AAAAAA
Virtual Therapeutic Moiety Irinotecan
Date identifier became valid 29 Oct 2018
Previous product identifier 327026002
Basis of preferred name rINN - Recommended International Non-proprietary
Date of name applicability 14 Jan 2009
Previous name Irinotecan 100mg/5ml solution for injection vials
Basis of previous name rINN - Recommended International Non-proprietary
Reason for name change Other
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 5.000
Unit dose form units ml
Unit dose unit of measure vial
Virtual Product Ingredient
Ingredient Irinotecan hydrochloride trihydrate
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 20.000
Strength value numerator unit mg
Strength value denominator 1.000
Strength value denominator unit ml
Ontology Drug Form & Route
Form & Route solutioninfusion.intravenous
Dose Form
Formulation Solution for infusion
Drug Route
Route Intravenous
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Campto 100mg/5ml concentrate for solution for infusion vials (Pfizer Ltd)
Irinotecan 100mg/5ml concentrate for solution for infusion vials (Accord-UK Ltd)
Irinotecan 100mg/5ml concentrate for solution for infusion vials (Consilient Health Ltd)
Irinotecan 100mg/5ml concentrate for solution for infusion vials (medac UK)
Irinotecan 100mg/5ml concentrate for solution for infusion vials (Pfizer Ltd)
Irinotecan 100mg/5ml concentrate for solution for infusion vials (Seacross Pharmaceuticals Ltd)
Virtual Medicinal Product Packs
Irinotecan 100mg/5ml solution for infusion vials 1 vial

dm+d data retrieved from TRUD: release NHSBSA_4.3.0_20240422000001, imported on 22nd April 2024 at 05:06:50.

Feedback